KarXT: an innovative and promising treatment for schizophrenia

Hands holding paper head, human brain with flowers, self care and mental health concept, positive thinking, creative mind

Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.

[read the full story...]

Schizophrenia and cannabis use: new evidence measures risk of relapse

Over 20% of cannabis users experience a psychotic relapse within 24 months of treatment.

In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.

[read the full story...]